Myomo (MYO) EBITDA Margin Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -283.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 72.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,505.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -184.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -3,846.00 |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3,617.00 |
| Jun 30, 2025 | 3,119.00 |
| Mar 31, 2025 | 3,500.00 |
| Dec 31, 2024 | 6,508.00 |
| Sep 30, 2024 | 3,591.00 |
| Jun 30, 2024 | 6,892.00 |
| Mar 31, 2024 | 2,193.00 |
| Dec 31, 2023 | -665.00 |
| Sep 30, 2023 | 9,225.00 |
| Jun 30, 2023 | 31,326.00 |
| Mar 31, 2023 | 26,198.00 |
| Dec 31, 2022 | 11,455.00 |
| Sep 30, 2022 | 39,467.00 |
| Jun 30, 2022 | 22,867.00 |
| Mar 31, 2022 | 25,240.00 |
| Dec 31, 2021 | 24,034.00 |
| Sep 30, 2021 | 39,844.00 |
| Jun 30, 2021 | 34,039.00 |
| Mar 31, 2021 | 64,175.00 |
| Dec 31, 2020 | 229,451.00 |
| Sep 30, 2020 | 16,163.00 |
| Jun 30, 2020 | 29,867.00 |
| Mar 31, 2020 | 703,181.00 |
| Dec 31, 2019 | 7,510.00 |
| Sep 30, 2019 | 4,128.00 |
| Jun 30, 2019 | -3,640.00 |